Ozempic, Wegovy to Offer Half-Price Weight Loss Drugs at Costco

The Costco Deal: What Actually Changed for GLP-1 Pricing

If you saw the headline about Ozempic and Wegovy going half-price at Costco, you probably did a double take. Weight loss drugs that normally run over $1,000 a month suddenly being available at a steep discount through a warehouse retailer sounds almost too good to be true. This video from TODAY breaks down what Novo Nordisk announced, how the Costco partnership works, and what it means for people who have been priced out of these medications. The short version: Novo Nordisk struck a deal to offer its GLP-1 drugs at a significant discount through Costco's pharmacy program, making semaglutide-based medications more accessible to people who either lack insurance coverage or whose plans refuse to cover weight loss drugs.

The timing here matters a lot. GLP-1 drugs have been under intense political and public scrutiny over pricing. Congressional hearings, social media outrage, investigative journalism, and the simple reality that most Americans cannot afford $1,300 a month for a medication have all put pressure on Novo Nordisk to do something about the price tag. This Costco deal is part of a broader strategy to get ahead of generic competition and public backlash. Whether it goes far enough is a different question entirely, but it represents one of the first major moves by a GLP-1 manufacturer to address cost directly through a retail channel rather than through the traditional pharmacy benefit manager system that has been widely criticized for opacity, rebate games, and middleman markups that keep consumer prices high even when manufacturers offer discounts.

It is also worth knowing what prompted this move from a competitive standpoint. Compounding pharmacies have been eating into Novo Nordisk's market share by offering semaglutide at $200-400 per month. Telehealth platforms have sprung up offering compounded versions with minimal friction, home delivery, and no insurance hassle. Every patient who goes the compounding route is a patient not buying brand-name Wegovy. The Costco deal can be read as Novo Nordisk's attempt to compete on price while maintaining control over the product and the brand narrative. If they can offer a meaningful discount through a trusted retail brand like Costco, some patients who were considering compounded alternatives might stick with the brand-name version because of the perceived safety and quality assurance that comes with an FDA-approved product from a major manufacturer.

How the Discount Actually Works

The video explains that the discount applies through Costco's member prescription program, which is separate from insurance. You do not need to use your health insurance to get the reduced price. This matters because one of the biggest barriers to GLP-1 access has been insurance companies refusing to cover these drugs for weight loss. Even when a doctor prescribes Wegovy or Ozempic for obesity, many plans classify it as a lifestyle medication and deny coverage outright. The Costco program sidesteps that problem entirely by creating a cash-pay pathway at a lower price point that does not require insurance approval, prior authorization, or appeals.

That said, half price is relative. Half of $1,300 is still $650, which is a lot of money for most households. The video touches on this but could have spent more time putting the numbers in context. For people who were already paying full retail price out of pocket, this is meaningful savings of over $600 per month. For someone making $50,000 a year, $650 a month is still roughly 15% of take-home pay, which is a huge financial commitment for a single medication. The deal moves the needle, but it does not solve the affordability crisis around these medications. It is more of a step in a long journey toward reasonable GLP-1 pricing. And for patients who were getting compounded semaglutide for $200-300 a month, the Costco deal is not competitive on price alone, though it does offer the assurance of a brand-name, FDA-approved product manufactured under strict quality controls.

There is also a logistics question that the video does not fully address. Not every Costco location has the same pharmacy inventory, and supply chain constraints on GLP-1 drugs have been real and ongoing. Even if the price is right, you still need the pharmacy to have the medication in stock. Patients in rural areas or regions with fewer Costco locations may not benefit equally from this deal. The online pharmacy option through Costco helps somewhat, but it adds shipping time and complexity, and it does not solve the underlying supply constraint if the medication itself is on backorder from the manufacturer.

What the Video Gets Right

The TODAY segment does a good job of explaining the mechanics of the deal in plain language. They correctly note that this is a cash-pay discount, not an insurance negotiation. They also mention that the deal covers both Ozempic (the diabetes-indicated version) and Wegovy (the weight loss-indicated version), which is an important distinction because coverage and pricing differ dramatically between the two even though the active ingredient is identical semaglutide. The segment also points out that you need a Costco membership, which adds another $60-120 per year to the cost, though Costco pharmacy services are technically available to non-members in most states due to pharmacy access laws that require pharmacies open to the public to serve all customers regardless of membership status.

What the Video Misses

The segment does not spend enough time discussing whether this deal will last or how it compares to other discount pathways that already exist. Manufacturer savings cards from Novo Nordisk can bring the cost down to $25 per month for commercially insured patients. Telehealth platforms offer bundled pricing that includes the prescription, medication, and ongoing support. Compounding pharmacies offer the lowest absolute prices. The video also does not mention that Costco's pharmacy pricing has historically been competitive even without special manufacturer deals, so the actual savings versus Costco's normal cash price may be less dramatic than the headline number suggests. There is also no discussion of how this deal might affect the compounding pharmacy ecosystem. If brand-name prices drop enough, it weakens the shortage-based legal justification for compounding, which could actually reduce options for patients who rely on compounded versions.

The segment also glosses over the long-term cost picture. GLP-1 medications are not typically short-term prescriptions. Clinical data shows that most patients regain weight after stopping these drugs, which means most patients are looking at years or potentially a lifetime of use. At $650 per month, that is nearly $8,000 per year, every year. Over a decade, a patient would spend close to $80,000 on the medication alone, not counting doctor visits, lab work, and other associated costs. Even at a significant discount, the lifetime cost of GLP-1 treatment is substantial, and the video does not prompt viewers to think about this long-term financial math when evaluating whether the Costco deal makes the medication truly affordable for them.

Questions to Bring to Your Doctor

If this deal caught your attention, here are some questions worth asking your prescriber. First, ask whether you are a candidate for semaglutide and whether Ozempic or Wegovy makes more sense for your situation, since the two have different approved uses and your insurance may cover one but not the other. Second, ask about all the cost-reduction options available to you, more than the Costco deal. Manufacturer coupons, patient assistance programs, compounding pharmacies, and telehealth platforms may offer even better pricing depending on your insurance status and income level. Third, ask about the realistic timeline for treatment, since GLP-1 medications are not typically short-term prescriptions and you need to budget for ongoing monthly costs, more than the first fill. Fourth, ask whether there are clinical trials you might qualify for that provide the medication at no cost. Fifth, ask your doctor to compare the total cost of different GLP-1 options, more than semaglutide, since tirzepatide or other medications might be more affordable through your specific insurance plan.

Who Should Watch This

This video is most useful for people who have already talked to their doctor about GLP-1 medications but hit a wall on cost. If you have been paying full retail price out of pocket, the Costco deal is worth investigating as one option among several. If you have insurance that covers these drugs with a reasonable copay, this deal may not be relevant since your copay could already be lower than the Costco discounted price. It is also worth watching if you are just starting to research weight loss medication options and want to understand the pricing space, since the segment provides a good entry point for understanding why GLP-1 costs are so high and what forces are starting to bring them down.

The bigger takeaway from this story is that the GLP-1 pricing model is under pressure from multiple directions simultaneously. Between Costco deals, compounding pharmacies, telehealth platforms, political pressure from Congress, state-level legislative mandates, and upcoming patent expirations, the days of $1,300 monthly price tags are likely numbered. But for now, most people still face significant out-of-pocket costs, and any step toward affordability is worth paying attention to. The question that remains unanswered is whether these incremental changes will add up fast enough to help the tens of millions of people who could benefit from these drugs but simply cannot afford them at current prices.